• Toshiyuki Tony Watanabe, Masahiko Ichijo, and Tomoyuki Kamata.
• Department of Neurology, Japanese Red Cross Musashino Hospital, Musashino, Tokyo, Japan. Electronic address: tonynuro@tmd.ac.jp.
• J Stroke Cerebrovasc Dis. 2019 Jan 1; 28 (1): 70-75.

BackgroundIntravenous thrombolysis with recombinant tissue plasminogen activator and endovascular mechanical thrombectomy are known to be the most effective treatments in the acute phase of ischemic stroke. However, the safety of intravenous systemic thrombolysis with recombinant tissue plasminogen and endovascular mechanical thrombectomy during pregnancy is not well-confirmed. We describe a case of an uneventful pregnancy and delivery after thrombolysis plus endovascular mechanical thrombectomy for acute ischemic stroke.Materials And MethodsThe patient's medical records were reviewed retrospectively. A comprehensive systemic literature search of the PubMed database was conducted.Case PresentationA 36-year-old woman at 21 weeks gestation presented with a sudden headache, dysarthria, and right hemiparesis. Magnetic resonance angiography revealed occlusion of the left internal carotid artery. Recombinant tissue plasminogen activator was administered intravenously 193 minutes after symptom onset, and endovascular mechanical thrombectomy was started immediately. Recanalization of her left internal carotid artery was achieved. The patient continued to experience mild hemiparesis after the initial treatment and started rehabilitation. The fetus remained in satisfactory condition during the pregnancy and was delivered at 38 weeks without obvious maternal or neonatal complications. No apparent abnormality has been observed in the newborn in the first year of life.ConclusionsIntravenous recombinant tissue plasminogen and endovascular mechanical thrombectomy could be considered as treatment for acute ischemic stroke during pregnancy unless high risks of hemorrhage or preterm labor are expected.Copyright © 2018. Published by Elsevier Inc.

21 keywords...

hide…